What is call & gene therapy supply chains?
The premise of cell and gene therapy is treatment by correcting (cutting and pasting) or modifying (strengthening) a part of the patient’s DNA. The first therapy introduced was Kyriah. It is about strengthening the patient’s body to fight leukemia more effectively. Call & gene therapy supply chains differ significantly from traditional pharmaceutical supply chains. There is a need for robust supply chain processes already in the clinical trials stage. Hence the need for support in the implementation of capacity planning, as well as establishing a detailed schedule of quality and production operations in a plant producing, among others, gene therapy. You can find such help with us. Contact us and we will tell you everything exactly and dispel your doubts.
Why is effective call & gene therapy supply chains so important?
The number of treatments and patients continues to increase, and so do call & gene therapy supply chains. Patients must be cared for and treated appropriately. Cell and gene therapy supply chains must be legally operated to be able to serve the right people. The ability to react in real time is indicated here. That is why we have created a solution that will help with this. It is a digital planning and scheduling software for scientists and laboratory analysts, among others. Do you want to know more about this issue and our new technology? Contact us. We will be happy to provide you with all the most important information. Also, check out the greater adherence to quality control planning in laboratories.